OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 108 filers reported holding OCULAR THERAPEUTIX INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,181,592 | -80.5% | 224,211 | -23.4% | 0.23% | -76.6% |
| Q4 2020 | $6,059,000 | +210.6% | 292,722 | +14.2% | 0.99% | +114.3% |
| Q3 2020 | $1,951,000 | -32.3% | 256,397 | -25.9% | 0.46% | -27.3% |
| Q2 2020 | $2,883,000 | +68.3% | 346,075 | 0.0% | 0.64% | +19.7% |
| Q1 2020 | $1,713,000 | – | 346,075 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |